Basic Information | Post buying leads | Suppliers |
Name |
Trophosphamide |
EINECS | N/A |
CAS No. | 22089-22-1 | Density | 1.35g/cm3 |
PSA | 42.59000 | LogP | 2.77310 |
Solubility | N/A | Melting Point |
47-49°C |
Formula | C9H18 Cl3 N2 O2 P | Boiling Point | 393.7°Cat760mmHg |
Molecular Weight | 323.587 | Flash Point | 191.9°C |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by intraperitoneal, subcutaneous, and intravenous routes. Moderately toxic by ingestion. Human mutation data reported. Human systemic effects by unspecified routes: hematuria, leukopenia, and thrombocytopenia. When heated to decomposition it emits very toxic fumes of Cl−, NOx, and POx. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
2H-1,3,2-Oxazaphosphorine,2-[bis(2-chloroethyl)amino]-3-(2-chloroethyl)tetrahydro-, 2-oxide (8CI);3-(2-Chloroethyl)-2-[bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine2-oxide; Asta Z 4828; Ixoten; NSC 109723; Trifosfamide; Trilofosfamida;Trilophosphamide; Triphosphamide; Trisfosfamide; Trofosfamid; Trofosfamide; Trophosphamid;Trophosphamide; Z 4828 |
IUPAC Name: N,N,2-tris(2-chloroethyl)-1-oxo-6-oxa-2-aza-1λ5-phosphacyclohexan-1-amine
Molecular Formula: C9H18Cl3N2O2P
Molecular Weight: 323.61g/mol
EINECS: 244-770-8
Density: 1.35g/cm3
Boiling Point: 393.7°C at 760mmHg
Flash Point: 191.9°C
Freely Rotating Bonds: 7
Polar Surface Area: 42.59 Å2
Index of Refraction: 1.518
Molar Refractivity: 72.42 cm3
Molar Volume: 238.7 cm3
Polarizability: 28.7 ×10-24 cm3
Surface Tension: 46.1 dyne/cm
Enthalpy of Vaporization: 64.36 kJ/mol
Vapour Pressure: 2.09E-06 mmHg at 25°C
The Cas Register Number of Trophosphamide is 22089-22-1.The chemical synonyms of Trophosphamide (CAS NO.22089-22-1) are (R)-N,N,3-Tris(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide ; 2-[Bis(2-chloroethyl)amino]-3-(2-chloroethyl)tetrahydro-2H-1,3,2-oxaphosphorine 2-oxide ; 2H-1,3,2-oxazaphosphorin-2-amine, N,N,3-tris(2-chloroethyl)tetrahydro-, 2-oxide ; 2H-1,3,2-Oxazaphosphorin-2-amine, N,N,3-tris(2-chloroethyl)tetrahydro-, 2-oxide (9CI) ; 2H-1,3,2-Oxazaphosphorin-2-amine, N,N,3-tris(2-chloroethyl)tetrahydro-, 2-oxide, (R)- ; N,N,3-Tris(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide ; N,N,3-Tris(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine-2-Oxide ; Trilophosphamide ; 2-(Bis(2-chloroethyl)amino)-3-(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide ; 2H-1,3, 2-Oxazaphosphorine, 2-[bis (2-chloroethyl)amino]-3-(2-chloroethyl)tetrahydro-, 2-oxide ; 2H-1,3,2-Oxaphosphorin-2-amine, tetrahydro-N,N, 3-tris(2-chloroethyl)-, 2-oxide ; 2H-1,3,2-Oxazaphosphorin-2-amine, N,N,3-tris (2-chloroethyl)tetrahydro-, 2-oxide ; 2H-1,3,2-Oxazaphosphorin-2-amine, N,N,3-tris(2-chloroethyl)tetrahydro-, 2-oxide, (S)- ; 2H-1,3,2-Oxazaphosphorine, 2-(bis(2-chloroethyl)amino)-3-(2-chloroethyl)tetrahydro-, 2-oxide ; 3-(2-Chloroethyl)-2-(bis(2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine 2-oxide ; Cyclophosphamide, N-monochloroethyl derivative ; Ifosfamide mustard ; Ixoten ; N,N,3-Tris(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide ; N,N,N'-Tris(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide ; N,N-3'-tris(2-chloroethyl)tetrahydro-2H-1,3,2 oxazaphosphorin-2-amine, 2-oxide ; Trifosfamide .The molecular structure of Trophosphamide (CAS NO.22089-22-1) is.
Trophosphamide (CAS NO.22089-22-1) is used as anti carcinoma drug.
1. | mma-esc 10 mmol/L | ARTODN Archives of Toxicology. 33 (1975),225. | ||
2. | sln-dmg-unr 1 mmol/L/24H | MUREAV Mutation Research. 33 (1975),221. | ||
3. | cyt-hmn:leu 100 mg/L | HUMAA7 Humangenetik. 5 (1968),321. | ||
4. | cyt-rat-ipr 25 mg/kg | HUMAA7 Humangenetik. 5 (1968),321. | ||
5. | mnt-mus-ipr 80 mg/kg/24H | MUREAV Mutation Research. 56 (1978),319. | ||
6. | cyt-ham-ipr 3300 µg/kg | ARTODN Archives of Toxicology. 38 (1977),35. | ||
7. | unr-hmn TDLo:50 mg/kg:BLD,KID | SAMJAF South African Medical Journal. 53 (1978),886. | ||
8. | orl-rat LD50:202 mg/kg | MDACAP Medicamentos de Actualidad. 13 (1977),115. | ||
9. | scu-rat LD50:210 mg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 23 (1973),922. | ||
10. | ivn-rat LD50:90 mg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 23 (1973),922. | ||
11. | orl-mus LD50:464 mg/kg | MDACAP |
EPA Genetic Toxicology Program.
Poison by intraperitoneal, subcutaneous, and intravenous routes. Moderately toxic by ingestion. Human mutation data reported. Human systemic effects by unspecified routes: hematuria, leukopenia, and thrombocytopenia. When heated to decomposition it emits very toxic fumes of Cl−, NOx, and POx.